Table 1.
Patient characteristics and analysis results grouped to according to received N-acetylcysteine treatment.
| All patients | NAC in treat | No treat | P values* | |
|---|---|---|---|---|
| N | 70 | 35 | 35 | – |
| Male, (%) | 40 (57) | 20 (57) | 20 (57) | – |
| Female, (%) | 15 (43) | 15 (43) | 15 (43) | – |
| Age, year | 42±16 | 43±15 | 41±17 | a0.6715 |
| BMI, kg/m2 | 26.9±3.1 | 27.1±3.2 | 26.6±3.0 | a0.4437 |
| WC, cm | 93±9 | 91±9 | 94±8 | a0.1536 |
| Cigarette use, (%) | 25 (36) | 12 (34) | 13 (37) | b0.8383 |
| Alcohol use, (%) | 17 (24) | 7 (20) | 10 (29) | b0.5293 |
| Glucose, mg/dl | 98±16 | 99±15 | 98±17 | a0.7719 |
| Leukocyte, 103/ul | 7.6±1.3 | 7.5±1.4 | 7.7±1.2 | a0.5326 |
| Hematocrit,% | 43,4±5.8 | 43.7±5.3 | 43.0±6.4 | a0.6049 |
| Grade of COPD (FEV1) | 66.1±7.7 | 66.9±7.8 | 65.3±7.5 | a0.3874 |
*
Comparison between NAC in treat and no treat.
a
Unpaired t test;
b
Mann-Whitney Test,
BMI – Body mass index; WC – waist circumference; COPD – chronic obstructive pulmonary disease; FEV1 – volume taken at the first second of forced expiration. Glucose, Leukocyte, and hematocrit values belong to the preoperative period.